to Yusimry Humira has been one of the most expensive medications to cover on a pharmacy benefit for years
During this year, Pfizer received a record number of FDA New Molecular Entity approvals, including products such as Zavzpret, Paxlovid, Abrysvo (for OA+MI), Litfulo, Ngenla, Elrexfio, Comirnaty, Velsipity, and Penbraya
All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity
*Last updated: July 2026
Online searches uncovered dozens of unapproved peptide products aggressively promoted for rapid weight loss, muscle recovery, anti-aging and longevity